arrow_back Back to App

Risky Research Review: New Life Sciences Research Security Board

This act establishes a new Life Sciences Research Security Board to review federally funded research projects, particularly those deemed "high-risk." Its purpose is to protect public health and national security from potentially dangerous research, influencing which scientific projects receive funding and how they are conducted.
Key points
Establishment of an Independent Board: A Life Sciences Research Security Board is created to independently review federally funded research projects.
Review of High-Risk Research: The Board will determine whether government agencies can fund life sciences research that could pose risks to public health, safety, or the environment.
Mandatory Disclosure and Certification: Entities seeking federal funding must attest if their research is high-risk, and agencies will certify these attestations.
Penalties for Non-Compliance: Knowing failure to disclose risky research or comply with regulations can lead to penalties, including funding suspension and revocation of security clearances.
article Official text account_balance Process page
Placed on Calendar
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_854
Sponsor: Sen. Paul, Rand [R-KY]
Process start date: 2025-03-05
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Risky Research Review Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_854.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-03-05.

What are the main provisions?

Key points include:

  • Establishment of an Independent Board: A Life Sciences Research Security Board is created to independently review federally funded research projects.
  • Review of High-Risk Research: The Board will determine whether government agencies can fund life sciences research that could pose risks to public health, safety, or the environment.
  • Mandatory Disclosure and Certification: Entities seeking federal funding must attest if their research is high-risk, and agencies will certify these attestations.
  • Penalties for Non-Compliance: Knowing failure to disclose risky research or comply with regulations can lead to penalties, including funding suspension and revocation of security clearances.
What is the specific legal status?

The current status is Placed on Calendar.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Paul, Rand [R-KY].

What is the latest detailed status?

The latest detailed status is: Placed on Senate Legislative Calendar under General Orders. Calendar No. 164.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health Security